Blood Plasma Derivatives Market Is Estimated To Witness High Growth Owing To Increasing Demand For Plasma-derived Medicines
![]() |
Blood Plasma Derivatives Market |
The global Blood Plasma Derivatives
Market is estimated to be valued at US$
40.80 Bn In 2022 and is expected to exhibit a CAGR of 9.30% over the forecast period 2023-2030, as highlighted in
a new report published by Coherent Market Insights.
Market Overview: Blood plasma derivatives are products derived from blood
plasma, such as albumin, immunoglobulins, and clotting factors. These products
are used for various therapeutic indications, including immunodeficiency
disorders, hemophilia, and autoimmune diseases. The advantages of blood plasma
derivatives include their ability to replace or replenish deficient proteins in
the body, provide passive immunity, and control bleeding in patients with
clotting disorders. The increasing prevalence of these conditions and the
rising demand for plasma-derived medicines are driving the growth of the blood
plasma derivatives market.
Market key trends: An important key trend in the blood plasma derivatives
market is the increasing demand for plasma-derived medicines. Plasma-derived
medicines are essential for the treatment of various medical conditions,
including immune deficiencies, autoimmune diseases, and bleeding disorders. The
demand for these medicines is growing due to the increasing global prevalence
of these conditions and the expanding aging population. In addition,
advancements in plasma fractionation techniques and the development of novel
plasma-derived therapies are further fueling market growth. Moreover, the
growing awareness among healthcare professionals and patients about the
benefits of plasma-derived medicines is also contributing to market expansion.
PEST Analysis:
Political: The political factors influencing the blood plasma derivatives
market are mainly focused on regulations and government policies. Government
regulations play a crucial role in the approval process of plasma derivatives,
which can vary from country to country. Additionally, political stability is
important to ensure smooth operations and trade of blood plasma derivatives
across different regions.
Economic: The economic factors affecting the Blood
Plasma Derivatives Market include healthcare expenditure, insurance
coverage, and the overall economic stability in different regions. Increasing
healthcare expenditure and rising prevalence of chronic diseases are expected
to drive market growth. Additionally, advancements in healthcare infrastructure
and increased insurance coverage in emerging economies are expected to boost
market demand.
Social: The social factors influencing the market include increasing awareness
about blood plasma derivatives, changing lifestyles, and a growing aging
population. Rising awareness about the benefits of blood plasma derivatives in
treating various diseases is driving market growth. Moreover, lifestyle
changes, such as unhealthy dietary habits and lack of physical activity, have
led to an increased prevalence of diseases that require plasma derivatives for
treatment.
Technological: Technological advancements have played a significant role in the
blood plasma derivatives market. Improved manufacturing techniques, such as
fractionation and viral inactivation, have enhanced the safety and purity of
plasma derivatives. Moreover, the development of new recombinant technologies
has expanded the range of plasma-derived products available in the market.
Key Takeaways:
The global blood plasma derivatives market is expected to witness high growth,
exhibiting a CAGR of 9.30% over the forecast period. This growth can be
attributed to several factors, including the increasing prevalence of chronic
diseases, advancements in healthcare infrastructure, and rising awareness about
the benefits of blood plasma derivatives.
In terms of regional analysis, North America is expected to be the
fastest-growing and dominating region in the blood plasma derivatives market.
This can be attributed to factors such as the presence of well-established
healthcare infrastructure, high healthcare expenditure, and increasing adoption
of advanced therapies in the region.
Key players operating in the blood plasma derivatives market include Shire
Plc., CSL Limited, Octapharma AG, LFB S.A., Biotest AG, Grifols, S.A., SK
Plasma Co., Ltd., Baxter International Inc., Green Cross Corporation, and
Fusion Health Care Pvt. Ltd. These companies are actively involved in research
and development activities, strategic collaborations, and mergers and
acquisitions to strengthen their market position and expand their product
offerings.
Comments
Post a Comment